The effects of Δ(9)-tetrahydrocannabinol (
THC), the psychoactive component of cannabis, on the function of
5-HT type 3 (5-HT(3)) receptors were investigated using a two-
electrode voltage clamp technique in Xenopus oocytes, and a whole-cell patch clamp technique in rat nodose ganglion neurons. In oocytes injected with 3 ng
cRNA of 5-HT(3A) receptor,
THC reversibly inhibited currents evoked with
5-HT (1 μM) in a concentration-dependent manner (IC(50)=1.2 μM). The extent of
THC inhibition was inversely correlated with the amount of
cRNA injected and the mean 5-HT(3A) receptor current densities. Pretreatment with
actinomycin D, which inhibits transcription, decreased the mean 5-HT(3) receptor current density and increased the extent of
THC inhibition on 5-HT(3) receptor-mediated currents. The IC(50) values for
THC increased from 285 nM to 1.2 μM in oocytes injected with 1 and 3 ng of 5-HT(3A)
cRNA, respectively. In radioligand binding studies on membrane preparations of oocytes expressing 5-HT(3A) receptors,
THC did not alter the specific binding of a 5-HT(3A) receptor antagonist, [(3)H]
GR65630. In the presence of 1 μM
THC, the maximum 5-HT-induced response was also inhibited without a significant change in
5-HT potency, indicating that
THC acts as a noncompetitive antagonist on 5-HT(3) receptors. In adult rat nodose ganglion neurons, application of 1 μM
THC caused a significant inhibition of 5-HT(3) receptors, extent of which correlated with the density of 5-HT-induced currents, indicating that the observed
THC effects occur in mammalian neurons. The inhibition of 5-HT(3) receptors by
THC may contribute to its pharmacological actions in nociception and
emesis.